| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 6.12e-07 | 37 | 89 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.08e-06 | 18 | 89 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 6.96e-06 | 28 | 89 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.70e-04 | 70 | 89 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | translation termination factor activity | 4.07e-04 | 7 | 89 | 2 | GO:0008079 | |
| GeneOntologyMolecularFunction | translation release factor activity | 4.07e-04 | 7 | 89 | 2 | GO:0003747 | |
| GeneOntologyMolecularFunction | aspartic endopeptidase activity, intramembrane cleaving | 5.41e-04 | 8 | 89 | 2 | GO:0042500 | |
| GeneOntologyBiologicalProcess | cell junction assembly | DOCK1 ACE2 DRD2 NRXN3 SETD5 EPHA2 LRP4 SRGAP2 IL1RAP ECT2 RAB29 CDH1 | 5.94e-06 | 569 | 89 | 12 | GO:0034329 |
| GeneOntologyBiologicalProcess | synapse assembly | 7.33e-06 | 308 | 89 | 9 | GO:0007416 | |
| GeneOntologyBiologicalProcess | glial cell-derived neurotrophic factor production | 1.84e-05 | 2 | 89 | 2 | GO:0044467 | |
| GeneOntologyBiologicalProcess | regulation of glial cell-derived neurotrophic factor production | 1.84e-05 | 2 | 89 | 2 | GO:1900166 | |
| GeneOntologyBiologicalProcess | positive regulation of glial cell-derived neurotrophic factor production | 1.84e-05 | 2 | 89 | 2 | GO:1900168 | |
| GeneOntologyBiologicalProcess | cell junction organization | DOCK1 ACE2 DRD2 NRXN3 GPR158 SETD5 EPHA2 LRP4 SPG11 SRGAP2 IL1RAP ECT2 RAB29 CDH1 | 6.99e-05 | 974 | 89 | 14 | GO:0034330 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular protein transport | 1.47e-04 | 116 | 89 | 5 | GO:0090316 | |
| GeneOntologyBiologicalProcess | localization within membrane | NRXN3 GPR158 EPHA2 TM9SF3 EXOC6B LRP4 PRPH2 SPG11 RAB29 CDH1 VPS53 SORL1 | 1.60e-04 | 798 | 89 | 12 | GO:0051668 |
| GeneOntologyBiologicalProcess | synapse organization | DOCK1 DRD2 NRXN3 GPR158 SETD5 LRP4 SPG11 SRGAP2 IL1RAP RAB29 CDH1 | 1.74e-04 | 685 | 89 | 11 | GO:0050808 |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.79e-06 | 25 | 90 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | inner dynein arm | 9.06e-06 | 10 | 90 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | translation release factor complex | 5.48e-05 | 3 | 90 | 2 | GO:0018444 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 7.60e-05 | 238 | 90 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | dynein complex | 8.62e-05 | 54 | 90 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | axoneme | 2.74e-04 | 207 | 90 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 2.81e-04 | 208 | 90 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ACE2 CD1B DRD2 SPPL2A PTPRB ATR OTOF ANO6 OSBPL6 OCA2 SNX21 DMD VPS53 SPPL2C SORL1 | 4.37e-04 | 1307 | 90 | 15 | GO:0030659 |
| GeneOntologyCellularComponent | cilium | SPTBN5 ACE2 NPR2 DRD2 DNAH12 KCNU1 WDR11 DNAH17 PGAM4 PRPH2 DNAH6 DNAH7 | 4.60e-04 | 898 | 90 | 12 | GO:0005929 |
| GeneOntologyCellularComponent | vesicle membrane | ACE2 CD1B DRD2 SPPL2A PTPRB ATR OTOF ANO6 OSBPL6 OCA2 SNX21 DMD VPS53 SPPL2C SORL1 | 5.05e-04 | 1325 | 90 | 15 | GO:0012506 |
| GeneOntologyCellularComponent | vacuole | CD1B SPPL2A WDR11 OSBPL7 MIOS PSMD1 SPG11 OCA2 TRAF3IP3 RAB29 SPPL2C HYAL2 | 5.34e-04 | 913 | 90 | 12 | GO:0005773 |
| GeneOntologyCellularComponent | lateral plasma membrane | 6.19e-04 | 90 | 90 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | microtubule associated complex | 6.61e-04 | 161 | 90 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 7.18e-04 | 164 | 90 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | lysosomal membrane | 8.53e-04 | 462 | 90 | 8 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 8.53e-04 | 462 | 90 | 8 | GO:0098852 | |
| GeneOntologyCellularComponent | motile cilium | 8.58e-04 | 355 | 90 | 7 | GO:0031514 | |
| GeneOntologyCellularComponent | synaptic membrane | 9.11e-04 | 583 | 90 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | membrane raft | 9.61e-04 | 362 | 90 | 7 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 9.92e-04 | 364 | 90 | 7 | GO:0098857 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.16e-03 | 48 | 90 | 3 | GO:0098576 | |
| GeneOntologyCellularComponent | vacuolar membrane | 1.54e-03 | 507 | 90 | 8 | GO:0005774 | |
| GeneOntologyCellularComponent | trans-Golgi network | 2.08e-03 | 306 | 90 | 6 | GO:0005802 | |
| GeneOntologyCellularComponent | dendritic spine head | 2.12e-03 | 16 | 90 | 2 | GO:0044327 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | AKAP6 RANBP2 SYNE1 OSBPL7 OSBPL6 DMD RAB29 CDH1 VPS53 HYAL2 SORL1 | 2.21e-03 | 934 | 90 | 11 | GO:0048471 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 2.49e-03 | 317 | 90 | 6 | GO:0032838 | |
| GeneOntologyCellularComponent | lysosome | CD1B SPPL2A WDR11 MIOS PSMD1 SPG11 OCA2 TRAF3IP3 SPPL2C HYAL2 | 2.54e-03 | 811 | 90 | 10 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | CD1B SPPL2A WDR11 MIOS PSMD1 SPG11 OCA2 TRAF3IP3 SPPL2C HYAL2 | 2.54e-03 | 811 | 90 | 10 | GO:0000323 |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 3.02e-03 | 443 | 90 | 7 | GO:0098791 | |
| GeneOntologyCellularComponent | lamellipodium | 3.18e-03 | 230 | 90 | 5 | GO:0030027 | |
| GeneOntologyCellularComponent | plasma membrane raft | 3.76e-03 | 147 | 90 | 4 | GO:0044853 | |
| GeneOntologyCellularComponent | cytoplasmic side of endoplasmic reticulum membrane | 4.00e-03 | 22 | 90 | 2 | GO:0098554 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | AKAP6 RANBP2 SPPL2A OTOF SYNE1 OSBPL7 OSBPL6 ANO5 OCA2 TRAF3IP3 PLD2 SPPL2C SORL1 | 4.37e-03 | 1327 | 90 | 13 | GO:0042175 |
| GeneOntologyCellularComponent | cytoplasmic region | 4.63e-03 | 360 | 90 | 6 | GO:0099568 | |
| Domain | EGF | 1.27e-05 | 235 | 86 | 8 | SM00181 | |
| Domain | Spectrin/alpha-actinin | 1.37e-05 | 32 | 86 | 4 | IPR018159 | |
| Domain | SPEC | 1.37e-05 | 32 | 86 | 4 | SM00150 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.31e-05 | 14 | 86 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 3.31e-05 | 14 | 86 | 3 | IPR013602 | |
| Domain | DHC_N2 | 3.31e-05 | 14 | 86 | 3 | PF08393 | |
| Domain | AAA_8 | 3.31e-05 | 14 | 86 | 3 | PF12780 | |
| Domain | Ldl_recept_b | 3.31e-05 | 14 | 86 | 3 | PF00058 | |
| Domain | LDLRB | 3.31e-05 | 14 | 86 | 3 | PS51120 | |
| Domain | DHC_fam | 4.12e-05 | 15 | 86 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 4.12e-05 | 15 | 86 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 4.12e-05 | 15 | 86 | 3 | PF03028 | |
| Domain | LY | 4.12e-05 | 15 | 86 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 4.12e-05 | 15 | 86 | 3 | IPR000033 | |
| Domain | Protein_Kinase_C_mu-related | 6.27e-05 | 3 | 86 | 2 | IPR015727 | |
| Domain | PH_dom-like | 1.50e-04 | 426 | 86 | 9 | IPR011993 | |
| Domain | EGF-like_dom | 1.51e-04 | 249 | 86 | 7 | IPR000742 | |
| Domain | Actinin_actin-bd_CS | 1.56e-04 | 23 | 86 | 3 | IPR001589 | |
| Domain | Spectrin | 1.56e-04 | 23 | 86 | 3 | PF00435 | |
| Domain | ACTININ_2 | 1.56e-04 | 23 | 86 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.56e-04 | 23 | 86 | 3 | PS00019 | |
| Domain | EGF-like_CS | 2.02e-04 | 261 | 86 | 7 | IPR013032 | |
| Domain | Peptidase_A22B_SPP | 2.08e-04 | 5 | 86 | 2 | IPR007369 | |
| Domain | Peptidase_A22B | 2.08e-04 | 5 | 86 | 2 | PF04258 | |
| Domain | EGF_2 | 2.21e-04 | 265 | 86 | 7 | PS01186 | |
| Domain | PH | 2.96e-04 | 278 | 86 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 3.02e-04 | 279 | 86 | 7 | PS50003 | |
| Domain | PH_domain | 3.09e-04 | 280 | 86 | 7 | IPR001849 | |
| Domain | Spectrin_repeat | 3.16e-04 | 29 | 86 | 3 | IPR002017 | |
| Domain | Anoct_dimer | 4.34e-04 | 7 | 86 | 2 | PF16178 | |
| Domain | Anoct_dimer | 4.34e-04 | 7 | 86 | 2 | IPR032394 | |
| Domain | PSN | 4.34e-04 | 7 | 86 | 2 | SM00730 | |
| Domain | Preselin/SPP | 4.34e-04 | 7 | 86 | 2 | IPR006639 | |
| Domain | - | 4.39e-04 | 391 | 86 | 8 | 2.30.29.30 | |
| Domain | Transl_elong_EFTu/EF1A_C | 5.76e-04 | 8 | 86 | 2 | IPR004160 | |
| Domain | GTP_EFTU_D3 | 5.76e-04 | 8 | 86 | 2 | PF03143 | |
| Domain | PH | 6.61e-04 | 229 | 86 | 6 | PF00169 | |
| Domain | G_TR_CS | 7.39e-04 | 9 | 86 | 2 | IPR031157 | |
| Domain | EGF_3 | 7.56e-04 | 235 | 86 | 6 | PS50026 | |
| Domain | - | 7.64e-04 | 39 | 86 | 3 | 2.120.10.30 | |
| Domain | Transl_elong_EF1A/Init_IF2_C | 9.21e-04 | 10 | 86 | 2 | IPR009001 | |
| Domain | Anoctamin | 9.21e-04 | 10 | 86 | 2 | PF04547 | |
| Domain | Anoctamin | 9.21e-04 | 10 | 86 | 2 | IPR007632 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.24e-03 | 46 | 86 | 3 | IPR011042 | |
| Domain | Oxysterol-bd | 1.34e-03 | 12 | 86 | 2 | IPR000648 | |
| Domain | Oxysterol-bd_CS | 1.34e-03 | 12 | 86 | 2 | IPR018494 | |
| Domain | Oxysterol_BP | 1.34e-03 | 12 | 86 | 2 | PF01237 | |
| Domain | OSBP | 1.34e-03 | 12 | 86 | 2 | PS01013 | |
| Domain | G_TR_1 | 1.58e-03 | 13 | 86 | 2 | PS00301 | |
| Domain | Dynein_HC_stalk | 1.84e-03 | 14 | 86 | 2 | IPR024743 | |
| Domain | MT | 1.84e-03 | 14 | 86 | 2 | PF12777 | |
| Domain | ATPase_dyneun-rel_AAA | 1.84e-03 | 14 | 86 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.84e-03 | 14 | 86 | 2 | PF07728 | |
| Domain | EGF | 2.74e-03 | 126 | 86 | 4 | PF00008 | |
| Domain | EFTu-like_2 | 3.06e-03 | 18 | 86 | 2 | IPR004161 | |
| Domain | GTP_EFTU_D2 | 3.06e-03 | 18 | 86 | 2 | PF03144 | |
| Domain | G_TR_2 | 3.06e-03 | 18 | 86 | 2 | PS51722 | |
| Domain | CH | 3.35e-03 | 65 | 86 | 3 | SM00033 | |
| Domain | TF_GTP-bd_dom | 3.41e-03 | 19 | 86 | 2 | IPR000795 | |
| Domain | PA | 3.41e-03 | 19 | 86 | 2 | PF02225 | |
| Domain | PA_domain | 3.41e-03 | 19 | 86 | 2 | IPR003137 | |
| Domain | CH | 4.13e-03 | 70 | 86 | 3 | PF00307 | |
| Domain | DAG/PE-bd | 4.16e-03 | 21 | 86 | 2 | IPR020454 | |
| Domain | - | 4.30e-03 | 71 | 86 | 3 | 1.10.418.10 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.25e-05 | 27 | 76 | 4 | M47755 | |
| Pathway | REACTOME_INDUCTION_OF_CELL_CELL_FUSION | 4.14e-05 | 13 | 76 | 3 | M46426 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 8.21e-05 | 43 | 76 | 4 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 9.83e-05 | 45 | 76 | 4 | M47670 | |
| Pubmed | 4.11e-08 | 14 | 90 | 4 | 9373155 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 30841931 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 15987998 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 35670331 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 37044359 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 19048396 | ||
| Pubmed | The anaphase promoting complex induces substrate degradation during neuronal differentiation. | 6.62e-06 | 2 | 90 | 2 | 19047054 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 36866798 | ||
| Pubmed | Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis. | 6.62e-06 | 2 | 90 | 2 | 14767510 | |
| Pubmed | Protein kinase d isoforms differentially modulate cofilin-driven directed cell migration. | 6.62e-06 | 2 | 90 | 2 | 24840177 | |
| Pubmed | ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis. | 6.62e-06 | 2 | 90 | 2 | 24695436 | |
| Pubmed | Increasing LRP4 diminishes neuromuscular deficits in a mouse model of Duchenne muscular dystrophy. | 6.62e-06 | 2 | 90 | 2 | 33987657 | |
| Pubmed | Opposing growth regulatory roles of protein kinase D isoforms in human keratinocytes. | 6.62e-06 | 2 | 90 | 2 | 25802335 | |
| Pubmed | Signal peptide peptidase-like 2c impairs vesicular transport and cleaves SNARE proteins. | 6.62e-06 | 2 | 90 | 2 | 30733281 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 23393329 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 24981173 | ||
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 8.44e-06 | 183 | 90 | 6 | 31932471 | |
| Pubmed | RANBP2 NRXN3 GSPT2 SETD5 SYNE1 TM9SF3 PGAM4 DNAJC21 PSMD1 SPG11 DMD CDH1 DNAH6 GSPT1 | 1.97e-05 | 1442 | 90 | 14 | 35575683 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 36397361 | ||
| Pubmed | Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer. | 1.98e-05 | 3 | 90 | 2 | 26253275 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 27662904 | ||
| Pubmed | Polypeptide chain release factor eRF3 is a novel molecular partner of survivin. | 1.98e-05 | 3 | 90 | 2 | 23377885 | |
| Pubmed | Effect of deletion of the protein kinase PRKD1 on development of the mouse embryonic heart. | 1.98e-05 | 3 | 90 | 2 | 38419169 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 9712840 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 8769098 | ||
| Pubmed | Expression of the protein kinase D (PKD) family during mouse embryogenesis. | 1.98e-05 | 3 | 90 | 2 | 16377259 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 32747433 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 26426580 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 14593528 | ||
| Pubmed | APC(cdh1) mediates degradation of the oncogenic Rho-GEF Ect2 after mitosis. | 1.98e-05 | 3 | 90 | 2 | 21886810 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 24569073 | ||
| Pubmed | Degradation of SARS-CoV-2 receptor ACE2 by the E3 ubiquitin ligase Skp2 in lung epithelial cells. | 3.96e-05 | 4 | 90 | 2 | 33511555 | |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 23362269 | ||
| Pubmed | Structural insights into eRF3 and stop codon recognition by eRF1. | 3.96e-05 | 4 | 90 | 2 | 19417105 | |
| Pubmed | Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network. | 3.96e-05 | 4 | 90 | 2 | 14743217 | |
| Pubmed | Protein kinase D regulates positive selection of CD4+ thymocytes through phosphorylation of SHP-1. | 3.96e-05 | 4 | 90 | 2 | 27670070 | |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 23031429 | ||
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 15385547 | ||
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 16829952 | ||
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 25651564 | ||
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 39056782 | ||
| Pubmed | Novel class of polytopic proteins with domains associated with putative protease activity. | 6.59e-05 | 5 | 90 | 2 | 12139484 | |
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 19047013 | ||
| Pubmed | Centralspindlin and α-catenin regulate Rho signalling at the epithelial zonula adherens. | 6.59e-05 | 5 | 90 | 2 | 22750944 | |
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 17601983 | ||
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 29759113 | ||
| Pubmed | Protein kinase D regulates RhoA activity via rhotekin phosphorylation. | 6.59e-05 | 5 | 90 | 2 | 22228765 | |
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 14685257 | ||
| Pubmed | Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. | 8.65e-05 | 89 | 90 | 4 | 27034005 | |
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 28599846 | ||
| Pubmed | Further analysis of the lens of ephrin-A5-/- mice: development of postnatal defects. | 9.87e-05 | 6 | 90 | 2 | 23401654 | |
| Pubmed | Planar cell polarity governs the alignment of the nasopharyngeal epithelium in mammals. | 9.87e-05 | 6 | 90 | 2 | 32452625 | |
| Pubmed | Identification and characterization of TMEM16E and TMEM16F genes in silico. | 9.87e-05 | 6 | 90 | 2 | 15067359 | |
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 17194762 | ||
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 23166357 | ||
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 20424596 | ||
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 10358005 | ||
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 20717963 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | ACE2 SPPL2A FCGBP ANO6 PGAM4 GBE1 NID1 GNAL CDH1 LRG1 B3GNT8 | 1.00e-04 | 1070 | 90 | 11 | 23533145 |
| Pubmed | 1.38e-04 | 7 | 90 | 2 | 17418107 | ||
| Pubmed | ANOs 3-7 in the anoctamin/Tmem16 Cl- channel family are intracellular proteins. | 1.38e-04 | 7 | 90 | 2 | 22075693 | |
| Pubmed | Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint. | 1.38e-04 | 7 | 90 | 2 | 20818375 | |
| Pubmed | Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b. | 1.38e-04 | 7 | 90 | 2 | 17965014 | |
| Pubmed | 1.38e-04 | 7 | 90 | 2 | 9856994 | ||
| Pubmed | 1.38e-04 | 7 | 90 | 2 | 19160489 | ||
| Pubmed | Mouse fundus photography and angiography: a catalogue of normal and mutant phenotypes. | 1.38e-04 | 7 | 90 | 2 | 10493779 | |
| Pubmed | 1.47e-04 | 102 | 90 | 4 | 11214970 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.67e-04 | 313 | 90 | 6 | 38270169 | |
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 16505993 | ||
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 24965120 | ||
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 20056604 | ||
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 24760005 | ||
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 22946059 | ||
| Pubmed | A Presenilin-2-ARF4 trafficking axis modulates Notch signaling during epidermal differentiation. | 1.84e-04 | 8 | 90 | 2 | 27354375 | |
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 26474281 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 2.14e-04 | 974 | 90 | 10 | 28675297 | |
| Pubmed | Dual functions of ASCIZ in the DNA base damage response and pulmonary organogenesis. | 2.36e-04 | 9 | 90 | 2 | 20975950 | |
| Pubmed | 2.36e-04 | 9 | 90 | 2 | 30282023 | ||
| Pubmed | Mammalian hyperplastic discs homolog EDD regulates miRNA-mediated gene silencing. | 2.36e-04 | 9 | 90 | 2 | 21726813 | |
| Pubmed | 2.36e-04 | 9 | 90 | 2 | 9733766 | ||
| Pubmed | Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. | 2.94e-04 | 10 | 90 | 2 | 23532839 | |
| Pubmed | Anoctamin/TMEM16 family members are Ca2+-activated Cl- channels. | 2.94e-04 | 10 | 90 | 2 | 19015192 | |
| Pubmed | 2.94e-04 | 10 | 90 | 2 | 24692353 | ||
| Pubmed | 3.30e-04 | 126 | 90 | 4 | 17897319 | ||
| Pubmed | 3.41e-04 | 504 | 90 | 7 | 34432599 | ||
| Pubmed | GC-B Deficient Mice With Axon Bifurcation Loss Exhibit Compromised Auditory Processing. | 3.59e-04 | 11 | 90 | 2 | 30275816 | |
| Pubmed | 3.59e-04 | 11 | 90 | 2 | 20454682 | ||
| Pubmed | 3.59e-04 | 11 | 90 | 2 | 26517967 | ||
| Pubmed | Loss of nidogen-1 and -2 results in syndactyly and changes in limb development. | 3.59e-04 | 11 | 90 | 2 | 17023412 | |
| Pubmed | 3.59e-04 | 11 | 90 | 2 | 11483621 | ||
| Pubmed | A family of 12 human genes containing oxysterol-binding domains. | 4.30e-04 | 12 | 90 | 2 | 11735225 | |
| Pubmed | 4.30e-04 | 12 | 90 | 2 | 22770219 | ||
| Pubmed | An oxysterol-binding protein family identified in the mouse. | 4.30e-04 | 12 | 90 | 2 | 12215260 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 4.51e-04 | 377 | 90 | 6 | 38117590 | |
| Pubmed | A panel of sputum-based genomic marker for early detection of lung cancer. | 5.07e-04 | 13 | 90 | 2 | 20864512 | |
| Pubmed | 5.61e-04 | 145 | 90 | 4 | 28846114 | ||
| Pubmed | The DNA sequence, annotation and analysis of human chromosome 3. | 5.67e-04 | 62 | 90 | 3 | 16641997 | |
| Pubmed | 5.91e-04 | 14 | 90 | 2 | 39225402 | ||
| Pubmed | Cell-fate transition and determination analysis of mouse male germ cells throughout development. | 5.91e-04 | 14 | 90 | 2 | 34824237 | |
| Pubmed | 5.91e-04 | 14 | 90 | 2 | 16452507 | ||
| GeneFamily | Dyneins, axonemal | 2.36e-07 | 17 | 59 | 4 | 536 | |
| GeneFamily | Anoctamins | 4.63e-04 | 10 | 59 | 2 | 865 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 6.77e-04 | 12 | 59 | 2 | 670 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-07 | 197 | 90 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.66e-06 | 193 | 90 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.74e-06 | 194 | 90 | 6 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.82e-06 | 195 | 90 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.82e-06 | 195 | 90 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-06 | 109 | 90 | 5 | 0d4128af237afcc0adb4dfdd206fa3ddbe5b0e86 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Interneuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 8.68e-06 | 64 | 90 | 4 | fefabdf8d72a8f3caf78eb79d759edb475bdb2ad | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.18e-05 | 146 | 90 | 5 | 1e81ad3d6d5d5ad2f0176d2a9593a954d38fa294 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 157 | 90 | 5 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 163 | 90 | 5 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 163 | 90 | 5 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | normal-na-Lymphocytic_NK-natural_killer_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.53e-05 | 171 | 90 | 5 | d339840626211a7bf1a9eb8f14d6c9509ab05e1c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.60e-05 | 172 | 90 | 5 | 68fd03f2c8ee01fe46194400f74ede3830e00f34 | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.91e-05 | 176 | 90 | 5 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 178 | 90 | 5 | 5cc182e6faa7ba5b88378d2c953be29bbbb95a7e | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 178 | 90 | 5 | f9a16bc3f09c35c7d30e3809da024bc2dcf746ed | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.41e-05 | 182 | 90 | 5 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.41e-05 | 182 | 90 | 5 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.51e-05 | 193 | 90 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.51e-05 | 193 | 90 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.51e-05 | 193 | 90 | 5 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.62e-05 | 194 | 90 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | 4.74e-05 | 195 | 90 | 5 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba | |
| ToppCell | mLN-T_cell-gd_T|T_cell / Region, Cell class and subclass | 4.85e-05 | 196 | 90 | 5 | 8f476408cd5a4ea9d25c763c66565343d7989b38 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.97e-05 | 197 | 90 | 5 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.97e-05 | 197 | 90 | 5 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.97e-05 | 197 | 90 | 5 | d8355f07a53e771052f9ab6b38814365dfe8d9ae | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 5.09e-05 | 198 | 90 | 5 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.22e-05 | 199 | 90 | 5 | 0447f8f53389fe7c6ddc04a97d86e74122ea16f4 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.22e-05 | 199 | 90 | 5 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.65e-05 | 118 | 90 | 4 | 5f72022f4be3fb7ccec86dc05d37572833028886 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.65e-05 | 118 | 90 | 4 | 053c0986051e36fdc4c48b8067c137b6299b2f1b | |
| ToppCell | Control-Lymphoid_T/NK-NK_activated|Control / Disease group, lineage and cell class | 9.97e-05 | 119 | 90 | 4 | a258d91ac90d4174b6f203d7f96ba6e57c6003e7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.97e-05 | 119 | 90 | 4 | 28d6b0e9dda2fe4ca94ae9b95b7261618d0d9877 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.97e-05 | 119 | 90 | 4 | 0fdd5b093ac20a4bda0f7b623808eb3ad0bf68e2 | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.16e-05 | 195 | 89 | 7 | 5669_UP | |
| Drug | Lisuride (S)(-) [18016-80-3]; Up 200; 11.8uM; HL60; HG-U133A | 1.19e-05 | 196 | 89 | 7 | 2046_UP | |
| Drug | Propylthiouracil [51-52-5]; Up 200; 23.4uM; PC3; HT_HG-U133A | 1.32e-05 | 199 | 89 | 7 | 4076_UP | |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.32e-05 | 199 | 89 | 7 | 5784_DN | |
| Disease | Drug habituation | 2.36e-05 | 115 | 87 | 5 | C0013170 | |
| Disease | Substance-Related Disorders | 2.36e-05 | 115 | 87 | 5 | C0236969 | |
| Disease | Drug abuse | 2.36e-05 | 115 | 87 | 5 | C0013146 | |
| Disease | Drug Use Disorders | 2.36e-05 | 115 | 87 | 5 | C0013222 | |
| Disease | Drug Dependence | 2.36e-05 | 115 | 87 | 5 | C1510472 | |
| Disease | Substance Dependence | 2.36e-05 | 115 | 87 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 2.36e-05 | 115 | 87 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.36e-05 | 115 | 87 | 5 | C0029231 | |
| Disease | Prescription Drug Abuse | 2.36e-05 | 115 | 87 | 5 | C4316881 | |
| Disease | Substance abuse problem | 2.46e-05 | 116 | 87 | 5 | C0740858 | |
| Disease | gait measurement | 8.39e-05 | 150 | 87 | 5 | EFO_0007680 | |
| Disease | dystonia (implicated_via_orthology) | 5.56e-04 | 12 | 87 | 2 | DOID:543 (implicated_via_orthology) | |
| Disease | Benign neoplasm of stomach | 1.14e-03 | 17 | 87 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.14e-03 | 17 | 87 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.14e-03 | 17 | 87 | 2 | C0154060 | |
| Disease | Malignant neoplasm of breast | 1.24e-03 | 1074 | 87 | 10 | C0006142 | |
| Disease | Stomach Carcinoma | 1.74e-03 | 21 | 87 | 2 | C0699791 | |
| Disease | short-term memory | 1.92e-03 | 83 | 87 | 3 | EFO_0004335 | |
| Disease | infant body height | 2.09e-03 | 23 | 87 | 2 | EFO_0006785 | |
| Disease | traumatic brain injury (biomarker_via_orthology) | 2.27e-03 | 24 | 87 | 2 | DOID:0081292 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LQYDKDRWLSTQWRL | 451 | Q8TAA9 | |
| WICDQNLSDLYRWLQ | 301 | P02750 | |
| WKQRQARLEYEWDLV | 401 | Q75V66 | |
| IWCYLREESEADQWL | 91 | Q4G0I0 | |
| DTTQELWIYQREWQR | 596 | Q9H981 | |
| EWLEWEDRRRAAAQQ | 21 | Q96NS5 | |
| LWRIRWEELQFGNSE | 491 | P20594 | |
| WKEDNALWERDRNLL | 136 | Q6NSX1 | |
| WNLEDLAREQQRRWV | 521 | Q8IYM0 | |
| RWIEFCQLLSERLNW | 811 | P11532 | |
| NANWTWYLRATLDVA | 256 | P29016 | |
| SWDTYWDRNDPLRDV | 331 | Q6UXT9 | |
| ERAKLYRWDRDVSQW | 2936 | P49792 | |
| SWEDSSADWERRYLL | 126 | Q04671 | |
| WSDYEIVRLQLWDIA | 51 | O14966 | |
| EWIYKAWERRNEQDF | 241 | Q9H8V3 | |
| WKRRQAELEYEWDTV | 396 | Q4KMQ2 | |
| DWTDYNDFELQWLPR | 1286 | P23467 | |
| WVRNWQDKDVYRRLS | 141 | Q12891 | |
| LQLSVWDWDLRYSNA | 511 | A4FU01 | |
| WDWDLRYSNAQILQF | 516 | A4FU01 | |
| QDDLDWYQALVWSLL | 151 | Q5T848 | |
| LTLIWYWTRQDRDLE | 66 | Q9NPH3 | |
| NRETWYLSWALDTNQ | 246 | Q8IYD1 | |
| ADSDYLWRSLSLQRW | 36 | Q6X9E4 | |
| EETDWYLLNLFRLWW | 121 | Q8NBM8 | |
| TDSVRGNLYWTDWNR | 1071 | P14543 | |
| QWARYLRWDASTRSD | 36 | Q9Y4C0 | |
| WLAQLRYYWENENAR | 1191 | Q6ZR08 | |
| WLQEYQTWLDLRELE | 806 | Q9BZL6 | |
| WLQDYQTWLDLREFE | 831 | O94806 | |
| SLDYLQREWRFLWNF | 756 | A8MYU2 | |
| WNLENRFSCWYDADL | 16 | Q8N0Y7 | |
| RQLLDLFIQWDWSTY | 731 | Q9Y2D4 | |
| WKEEYDTRQASNRWE | 166 | Q5F1R6 | |
| TARARAWNNLDWALY | 356 | Q96RP7 | |
| QREAWVSNDTYWELR | 906 | Q9BZF3 | |
| WYLSWALDTNQEERD | 121 | P15170 | |
| SLDLFESIWNNRWLR | 256 | P38405 | |
| RDAQIRDSWLDNIDW | 111 | O95400 | |
| RIFLEWRTAVYNWAL | 646 | Q13535 | |
| FDWQRQLRYYWDIDL | 1406 | Q9C0G6 | |
| RFLLSNIRWWLEEYR | 336 | Q04446 | |
| LREWSTIWRQLYVQD | 96 | Q14185 | |
| WYADLLLRIRELEAW | 4296 | Q9UFH2 | |
| LQVSYDWNWRVDVTL | 4191 | Q9Y6R7 | |
| DQDNWLRTNWVYRGE | 76 | P29317 | |
| ELLRQWLDHWNWYDL | 2061 | Q8WXX0 | |
| LDYNERLWAWESWRS | 156 | Q9BYF1 | |
| LTQDRDWEAYWRLLF | 91 | Q8WXX5 | |
| LSWYDDDLERQNWSR | 6 | P14416 | |
| WESRRYSDLLLWDFL | 201 | Q7Z7M8 | |
| ITYRIWRDTANWLEI | 521 | P12830 | |
| LEEWWLNVAYLDVRI | 81 | Q9UKG9 | |
| SWWPDQRRRLYNANI | 716 | Q9HC10 | |
| EWWVTNNTYWRLRAE | 816 | Q9BZF2 | |
| IYFCDWQQAWERRES | 321 | A8K8P3 | |
| NEIYWDDWSQLSIFR | 971 | Q92673 | |
| ETWRLWQKFLDDYSR | 7996 | Q8NF91 | |
| PYSEQDLWDWLRNST | 81 | P58417 | |
| YEQRLQDQSLWWIFV | 361 | P58872 | |
| DRDDYVNIWWDQILS | 171 | Q16819 | |
| LRDNLEWLARATNWA | 386 | Q99460 | |
| YRNEDRWAWLLQDTL | 341 | Q8IUH8 | |
| WENRIRLWTDQYEEA | 206 | Q9C0A6 | |
| ALLEDDTYRWWLRLQ | 91 | Q11201 | |
| RNGWWQYDERTSREL | 111 | Q9NTX7 | |
| RQRLEQAEAWLACWE | 3426 | Q9NRC6 | |
| ERSLSYWWNRIQSLL | 411 | Q9C0B6 | |
| LLDFDSEYQELWDWL | 961 | Q13023 | |
| RWYRLASDESLWQTL | 126 | Q13309 | |
| EALWRYLTARHDWLN | 881 | Q96JI7 | |
| EEWRSQYEALKEDWR | 316 | Q9Y228 | |
| EWQLLDCAERTLYWD | 21 | Q5T5D7 | |
| WIENYRNLLDAWRFW | 696 | Q9NXC5 | |
| RSWLNNFRDYLWQLI | 51 | A6NGZ8 | |
| FRDWFEIQWISNRYL | 171 | P23942 | |
| SQESAWLEWALRLQD | 591 | Q8TB22 | |
| YREALALWANAWQLQ | 256 | Q969T3 | |
| FRNEDRWAWILQDIL | 306 | Q8TCT8 | |
| LLYQRASDDWWEGRH | 756 | O75044 | |
| WLLRRVLWSDSYQIA | 271 | Q6H3X3 | |
| DFSQDEWEWLNLAQR | 31 | Q6ECI4 | |
| QDVAWLDKIDRRYAW | 276 | Q5VIR6 | |
| DVWQLDLSSRWQLYR | 921 | Q9P2E3 | |
| DLSSRWQLYRLWLQL | 926 | Q9P2E3 | |
| LLNAEDYRWQWTSFL | 506 | Q9HD45 | |
| DEWGWLDSAQRNLYR | 246 | P59923 | |
| RADCWRILEHYQWDL | 641 | Q13470 | |
| WLWNQDASRDLLLAI | 121 | Q9BZH6 | |
| YRQARWWAQEITELA | 296 | O14939 | |
| WEEWNLLSEAQRCLY | 26 | B7Z6K7 | |
| DWVARNLYWTDTGRN | 1436 | O75096 |